Bharat Electronics' QRSAM order slips to September, third timeline shift
Order book steady at ₹72,258 cr, but two major program timetables — QRSAM and AMCA — have slipped materially from prior guidance.
What's new
- Q1 revenue up 25.3% to ₹5,533 crore, PBT up 8.8% to ₹1,403 crore.
- Order book at July 1 stood at ₹72,258 crore, with Q1 orders of ₹3,754 crore matching plan.
- Employee cost-to-turnover ratio guided to 12%, down from earlier 14% baseline.
- QRSAM order now expected by September 2026, pushed from March 2026.
Themes from the call
Program Timelines
QRSAM and AMCA timelines slipped materially; both now point to H2 FY27 receipt, creating near-term order inflow uncertainty.
Margins
EBITDA margin target remains 28% for FY27, but quarterly mix can swing between 25-31%; Q1 came in at 25.8%.
Capital allocation
Capex guided above ₹1,200 crore and R&D above ₹2,200 crore for FY27, with R&D intensity targeted to rise from 6.5% to 8%.
Guidance watch
- FY27 revenue growth target 15% (may exceed slightly); EBITDA margin target 28% (may exceed); order inflows >₹55,000 crore including QRSAM by September.
- QRSAM receipt expected by September 2026; AMCA RFP submission deadline August 27, 2026.
- Employee cost-to-turnover ratio expected around 12% post-January 2027 wage revision.
Risk flags
- QRSAM order timing has slipped repeatedly; procedural delays are outside BEL's control and further slippage is possible.
- AMCA RFP timeline also shifted; management did not reconcile the broader delay beyond a two-month extension.
- Employee cost ratio rebasing from 14% to 12% was not reconciled with prior guidance and could affect margin expectations if turnover growth slows.
Key quotes
-
"We are confident of achieving that by March."
— BEL management, October 2025 call (on QRSAM timing) -
"Our future outlook remains the same: revenue growth of 15.0%, EBITDA margin of 28.0%, and order inflows of more than Rs 55,000 crores including QRSAM."
— Manoj Jain, closing remarks, July 2026 call
The brief
BEL delivered a strong Q1 — revenue climbed 25% to ₹5,533 crore, and the order book stayed above ₹72,258 crore. Execution across LRSAM, MPR Arudhra, and Akash was broad. But the call's real news is elsewhere. The QRSAM order, which management had said with high confidence would land before March 2026, is now expected by September. This is the third timeline shift for the same program. The AMCA RFP also slipped, with the submission deadline pushed to August 27 from an earlier expectation of mid-February. Management attributes both to procedural delays beyond its control. Separately, the employee cost ratio was introduced at 12% of turnover, down from the 14% level cited in January. No reconciliation was offered. None of this undermines the quarter — working capital improved, raw material pressure was absent, and the company maintained all core FY27 targets. But guidance credibility is now a live question. The QRSAM delay is a pattern, not an exception. The September deadline is now the milestone to track.
BEL's Q1 execution is strong, but the third QRSAM delay tests guidance credibility. The September deadline is now the benchmark.